Arsenic trioxide in recurrent urothelial cancer: a cancer and leukemia group B phase II trial (CALGB 99903).
- Citation:
- Clin Genitourin Cancer vol 7 (3) E66-70
- Year:
- 2009
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- Received
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- Dean F Bajorin Susan Halabi Eric Small
- Networks:
- Study
- CALGB-99903
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- Aged, Aged, 80 and over, Antineoplastic Agents, Arsenicals, Female, Humans, Leukemia, Promyelocytic, Acute, Male, Middle Aged, Oxides, Recurrence, Survival Analysis, Treatment Outcome, Urinary Bladder Neoplasms, Urologic Neoplasms, Urothelium